Volift XC and other hyaluronic acid fillers: What's the difference? Key points for choosing

The difference between Volift XC and other hyaluronic acid fillers is first determined by viscoelasticity—a combination of elastic modulus (G'), viscosity, and cohesivity. Even within the same Vycross family, Voluma, Volift XC, and Volbella are stratified by elasticity level, and which one to choose depends on the injection depth and treatment goal. Zettis Beauty Clinic offers Treatments tailored to these considerations.

Indicators that determine filler differences—elastic modulus, viscosity, and cohesivity

The main indicators that influence the clinical behavior of HA fillers are elastic modulus (G'), viscosity modulus (G"), complex elastic modulus (η*), and cohesivity. High elasticity is said to provide shape retention (firmness) against muscle movement and gravity, while high viscosity reduces diffusion within tissue[1]. "Lift capacity" is governed not only by elasticity but also by cohesivity—the property that filler molecules resist separating from each other—according to current understanding[2].

Even within the same Vycross family, elasticity is stratified

Among the Vycross series to which Volift XC (VYC-17.5L) belongs,Volumа (injected on the deep periosteum) > Volift XC (Vycross, mid-layer) > Volbella (Vycross, superficial layer)is reported to have elasticity in that order[2]This hierarchical structure forms the clinical basis for differentiated use: Volumа for bolus injection into deep areas such as the cheekbone and jaw, Volift XC for area-based correction of the mid-face, and Volbella for delicate superficial correction of the lips and tear troughs.

Monophasic and biphasic formulation classification axes

Another classification axis is whether the formulation is monophasic or biphasic. According to textbooks, monophasic formulations (Juvéderm series, including Volift XC) are composed of cohesive gel, while biphasic formulations (Restylane series) contain HA particles of varying sizes[9]The higher the degree of cross-linking, the greater the resistance to degradation and the longer the duration tends to be, as shown in textbook knowledge[8]However, Fundarò et al. point out that there is no standardized methodology for measuring cohesivity and that protocols differ between manufacturers, which can lead to confusion among clinicians[3], and formulations should not be mechanically ranked based on a single indicator alone.

How is the surgical technique chosen? ——Combination of area, volume, and alternative methods

There is a textbook framework stating that the starting point for filler selection is the "defect parameters" of injection site, required volume, and other treatment modalities that can be considered[10]As evidence, there is an 18-month prospective randomized controlled trial comparing two formulations with different Cross-linking technologies (Tri-Hyal-based and Vycross-based), demonstrating that differences in Cross-linking technology within the same "Volumizer" category can lead to differences in clinical behavior[4]Recently, rather than classifications by formulation class such as monophasic/biphasic, focus has shifted to product-specific characteristics based on Cross-linking density and additives (such as lidocaine concentration, etc.)product-specific characteristicsincreasingly points out that it more strongly determines the behavior seen in actual clinical practice[5].

ease of dissolution (reversibility) also becomes a factor in material selection

Hyaluronic acid fillers are considered advantageous due to their reversibility—they can be dissolved with hyaluronidase, unlike other filler materials[11]However, it has been suggested that deeper volumizers with higher cross-linking degree and cohesivity tend to require larger amounts of hyaluronidase for dissolution[7]and taking into account the ease of correction, filler selection is important in preoperative consultation. Options including hybrid formulations (CaHA-CMC/CPM-HA) around the eyelids are also being organized and discussed in expert panels[6].